Kaybiotech

Delhi, India Founded: 2015 • Age: 11 yrs
Online platform selling medicines for various health conditions and treatments.

About Kaybiotech

Kaybiotech is a Healthcare company based in Delhi (India) founded in 2015. Online platform selling medicines for various health conditions and treatments. It operates on a B2C and D2C model. Its website kaybiotech.co draws about 681 thousand monthly visits. Its Indian entity Kay Biotech Private Limited reported revenue of β‚Ή27.33 Cr. Kaybiotech offers products and services including Glivec 400mg Tablet, Instgra Tablets 50mg, Sildenafil Citrate 100mg, Retino-A 0.1% Cream, and Forxiga 10mg Tablet. Its focus areas include Pharmaceuticals, Specialty Medicines, Anti-Cancer and HIV Drugs and Online Pharmacy.

Company details

Kay Biotech operates as an online pharmacy based in Delhi, India, offering a diverse range of pharmaceutical products including anti-cancer drugs, HIV treatments, and diabetes medications. They facilitate direct purchases through their website with discounted prices, secure payments, and global delivery options. The company serves individual customers by categorizing products for easy access and ensuring affordability through various deals.

  • Headquarters Delhi, India
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website kaybiotech.co
  • Social X Facebook Instagram
  • Legal Name Kay Biotech Private Limited
  • Date of Incorporation 15 Jun, 2015
  • Jurisdiction New Delhi, Delhi, India
Key Metrics
  • Annual Revenue
    ₹27.33 Cr

    FY 2024 · +11% YoY

  • Net Profit
    ₹6.9 Lakh

    FY 2024 · 0% margin

  • EBITDA
    ₹9.7 Lakh

    FY 2024 · 0% margin

Products & Services of Kaybiotech

Kaybiotech offers a comprehensive portfolio of products and services, including Glivec 400mg Tablet, Instgra Tablets 50mg, Sildenafil Citrate 100mg, Retino-A 0.1% Cream, and Forxiga 10mg Tablet.

Glivec 400mg Tablet
Anti Cancer

Tablet for cancer treatment and management

Instgra Tablets 50mg
HIV

Medication for HIV infection control

Sildenafil Citrate 100mg
Erectile Dysfunction

Treatment for erectile dysfunction symptoms

Retino-A 0.1% Cream
Cosmetic

Cream for skin care and condition improvement

Forxiga 10mg Tablet
Diabetes

Tablet for diabetes blood sugar regulation

Azicip 250 Mg
COVID 19

Antibiotic for infection-related treatments

Entavir 1 mg
Hepatitis

Medication for hepatitis virus management

Board of directors of Kay Biotech Private Limited (Kaybiotech)

Kay Biotech Private Limited is the primary company behind Kaybiotech. The boards of the 2 registered companies of Kaybiotech currently have 5 directors; the longest-serving is Jamnadas Malaviya, appointed in 2000. 3 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Jamnadas Malaviya
DIN 02416226
Whole-time director27 Jan 200026 yrs 9 moSunrise Remedies Private Limited
Sayed Abul Ala
DIN 07175698
Director15 Jun 201511 yrs 4 moKay Biotech Private Limited
Sayed Shamoon Ahmed
DIN 03426719
Director15 Jun 201511 yrs 4 moKay Biotech Private Limited
Sayed Abu Sualeh
DIN 03402189
Director15 Jun 201511 yrs 4 moKay Biotech Private Limited
Abhishek Jamanadas Malaviya
DIN 05347389
Whole-time director10 Dec 20187 yrs 10 moSunrise Remedies Private Limited

Financials of Kaybiotech

Figures of Kay Biotech Private Limited, the primary company behind Kaybiotech, for FY 2024. Revenue was ₹27.33 Cr (+11% year on year). Net profit was ₹6.9 Lakh (0% margin). EBITDA was ₹9.7 Lakh (0% margin). Revenue has grown at a compounded annual rate of +3% over three years and +48% over five years.

  • ₹27.33 CrRevenue · FY 2024 · +11% YoY
  • ₹6.9 LakhNet profit · 0% margin
  • ₹9.7 LakhEBITDA · 0% margin
  • ₹1 LakhPaid-up capital
  • +3%Revenue CAGR, 3 years
  • +48%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Kay Biotech Private Limited are on its company page.

Premium access

Detailed financial statements for Kaybiotech

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Web traffic of Kaybiotech

The website of Kaybiotech (kaybiotech.co) receives about 680.7K visits a month.

  • Monthly visits
    680.7K

    ▼ 6.7% vs previous month

Similar websites

Websites whose visitors overlap most with Kaybiotech. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
falconebiz.com
100%
959.8K#63,970View details
tofler.in
97%
556K#105,509View details
zaubacorp.com
96%
4.9M#12,689View details
tracxn.com
92%
2.9M#16,597View details
indiafilings.com
90%
2.1M#29,959View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 40 similar websites and full traffic analytics for Kaybiotech

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 40 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Kaybiotech

Kaybiotech was founded in 2015.

Kaybiotech is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.

The primary company behind Kaybiotech, Kay Biotech Private Limited, reported revenue of β‚Ή27.33 Cr for FY 2024, up 11% year on year.

Kay Biotech operates as an online pharmacy based in Delhi, India, offering a diverse range of pharmaceutical products including anti-cancer drugs, HIV treatments, and diabetes medications. They facilitate direct purchases through their website with discounted prices, secure payments, and global delivery options. The company serves individual customers by categorizing products for easy access and ensuring affordability through various deals.

Kaybiotech offers Glivec 400mg Tablet, Instgra Tablets 50mg, Sildenafil Citrate 100mg, Retino-A 0.1% Cream, and 3 more products and services.

Kaybiotech is associated with 2 legal entities: Kay Biotech Private Limited, Sunrise Remedies Private Limited.

The legal entities of Kaybiotech currently have 5 directors, including Sayed Abul Ala, Sayed Shamoon Ahmed, Sayed Abu Sualeh and others.

The website of Kaybiotech receives about 681 thousand visits a month.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available